Current Funding:

1. Funding Institution: National Institutes of Health 2R01AI-44076-06
   Grant Title: TPN-Induced Changes in Intestinal Intraepithelial Lymphocytes
   Percent Effort: 40%
   Principal Investigator : Daniel H. Teitelbaum
   Dates and funding amount: 07/01/2004 to 06/30/2009
   Direct costs: $1,000,000.
2. Funding Institution: National Institutes of Health
   Grant Title: Mechanisms of Adaptation in Human Short Bowel Syndrome
   Percent Effort: 2%
   Principal Investigator : Thomas R. Ziegler
   Dates and funding amount: 07/01/2004 to 06/30/2006
   Role: Data Safety Monitor

Completed:

Funding Institution: National Institutes of Health
Grant Title: The Role of the NK1-T Lymphocyte in the Aging Mouse.

Percent Effort: 30%
Principal Investigator : Daniel H. Teitelbaum
RO3 AG15675-01
Dates of participation: 4/98 to 3/00;
Direct Cost: $50,000.

Funding Institution: Food and Drug Administration
Grant Title: Prevention of TPN-Cholestasis with Cholecystokinin,

Percent Effort: 15%
Principal Investigator : Daniel H. Teitelbaum
FD-R-001449-01
Dates of participation: 9/97 to 8/02;
Direct costs: $524,410.

Funding Institution: Maternal and Child Health EMSC Ð NDDP Program 1U03 MC 00003-01
Grant Title: EMSC Network Development Demonstration Project

Percent Effort: 10%
Principal Investigator : Ronald Maio
CandidateÕs role on the grant: Co-Investigator
Dates of participation: 10/01/01 to 10/30/02
Direct costs: $1,762,918

Funding Institution: National Institutes of Health
Grant Title: TPN-Induced Changes in Intestinal Intraepithelial Lymphocytes.

Percent Effort: 50%
Principal Investigator : Daniel H. Teitelbaum
1 R29 AI44076-01.
Dates and funding amount: 7/1999 to 6/2004;
Direct costs: $350,000.